Potential of Compounds Originating from the Nature to Act in Hepatocellular Carcinoma Therapy by Targeting the Tumor Immunosuppressive Microenvironment: A Review

• Published in: Molecules (Basel, Switzerland) Vol. 28; no. 1; p. 195
• Main Authors: Li, Yunheng, Li, Hui, He, Qiaojun, Yang, Xiaochun
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 26.12.2022; MDPI
• Subjects: Antigens; Apoptosis; Cancer; Cancer immunotherapy; Carcinoma, Hepatocellular - pathology; Care and treatment; Cytokines; Cytotoxicity; Fibroblasts; Flavonoids; Hassan, Muhammad; Hepatocellular carcinoma; Hepatoma; Humans; immune suppression; Immunological tolerance; Immunomodulation; Immunoregulation; Immunosuppressive agents; Immunotherapy; Liver; Liver cancer; Liver Neoplasms - pathology; Lymphocytes; Metastases; Microenvironments; Natural products; Polyphenols; Regulation; Review; TME; Toxicity; Treatment Outcome; Tumor Microenvironment; Tumors; China; natural products; immune suppression; TME; hepatocellular carcinoma; immunotherapy
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules28010195

Hepatocellular carcinoma (HCC), the most prevalent subtype of liver cancer, is the second main reason for cancer-related deaths worldwide. In recent decades, sufficient evidence supported that immunotherapy was a safe and effective treatment option for HCC. However, tolerance and frequent recurrence and metastasis occurred in patients after immunotherapy due to the complicated crosstalk in the tumor immunosuppressive microenvironment (TIME) in HCC. Therefore, elucidating the TIME in HCC and finding novel modulators to target TIME for attenuating immune suppression is critical to optimize immunotherapy. Recently, studies have shown the potentially immunoregulatory activities of natural compounds, characterized by multiple targets and pathways and low toxicity. In this review, we concluded the unique role of TIME in HCC. Moreover, we summarized evidence that supports the hypothesis of natural compounds to target TIME to improve immunotherapy. Furthermore, we discussed the comprehensive mechanisms of these natural compounds in the immunotherapy of HCC. Accordingly, we present a well-grounded review of the naturally occurring compounds in cancer immunotherapy, expecting to shed new light on discovering novel anti-HCC immunomodulatory drugs from natural sources.